{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["PPAR\u03b1", "atorvastatin", "diabetic kidney disease", "fenofibrate", "lipid metabolism disorders", "miR-21", "mitochondrial dynamics"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35222033", "DateRevised": {"Year": "2022", "Month": "03", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "11"}], "Language": ["eng"], "ELocationID": ["819787", "10.3389/fphar.2022.819787"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Atorvastatin Restores PPAR\u03b1 Inhibition of Lipid Metabolism Disorders by Downregulating miR-21 Expression to Improve Mitochondrial Function and Alleviate Diabetic Nephropathy Progression.", "Pagination": {"StartPage": "819787", "MedlinePgn": "819787"}, "Abstract": {"AbstractText": ["Atorvastatin is a classical lipid-lowering drug. It has been reported to have renoprotective effects, such as reducing urinary protein excretion and extracellular matrix aggregation. The present study aimed to investigate the specific mechanism of action of Atorvastatin in type 1 diabetic mice (T1DM) in inhibiting renal tubular epithelial cell injury following treatment with high glucose and high fat. The anti-injury mechanism of Atorvastatin involved the inhibition of miR-21 expression and the upregulation of the transcription and expression of its downstream gene Peroxisome proliferator-activated receptors-\u03b1(PPAR\u03b1). An increase in blood glucose and lipid levels was noted in the T1DM model, which was associated with renal fibrosis and inflammation. These changes were accompanied by increased miR-21 levels, downregulation of PPAR\u03b1 and Mfn1 expressions, and upregulation of Drp1 and IL6 expressions in renal tissues. These phenomena were reversed following the administration of Atorvastatin. miR-21 targeted PPAR\u03b1 by inhibiting its mRNA translation. Inhibition of miR-21 expression or Fenofibrate (PPAR\u03b1 agonist) administration prevented the decrease of PPAR\u03b1 in renal tubular epithelial cells under high glucose (HG) and high fat (Palmitic acid, PA) conditions, alleviating lipid metabolism disorders and reducing mitochondrial dynamics and inflammation. Consistent with the <i>in vivo</i> results, the <i>in vitro</i> findings also demonstrated that mRTECs administered with Atorvastatin in HG + PA increased PPAR\u03b1 expression and restored the normal expression of Mfn1 and Drp1, and effectively increasing the number of biologically active mitochondria and ATP content, reducing ROS production, and restoring mitochondrial membrane potential following Atorvastatin intervention. In addition, these effects were noted to the inhibition of FN expression and tubular cell inflammatory response; however, in the presence of miR-21mimics, the aforementioned effects of Atorvastatin were significantly diminished. Based on these observations, we conclude that Atorvastatin inhibits tubular epithelial cell injury in T1DM with concomitant induction of lipid metabolism disorders by a mechanism involving inhibition of miR-21 expression and consequent upregulation of PPAR\u03b1 expression. Moreover, Atorvastatin regulated lipid metabolism homeostasis and PPAR\u03b1 to restore mitochondrial function. The results emphasize the potential of Atorvastatin to exhibit lipid-regulating functions and non-lipid effects that balance mitochondrial dynamics."], "CopyrightInformation": "Copyright \u00a9 2022 Xiang, Zhang, Zhou, Wang, Chen, Tan, Liang, Shi, Zhang, Xiao, Zhou, Wang and Guo."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guizhou, China."}, {"Identifier": [], "Affiliation": "International Scientific and Technological Cooperation Base of Pathogenesis and Drug Research on Common Major Diseases, Guizhou Medical University, Guizhou, China."}], "LastName": "Xiang", "ForeName": "Jiayi", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guizhou, China."}, {"Identifier": [], "Affiliation": "International Scientific and Technological Cooperation Base of Pathogenesis and Drug Research on Common Major Diseases, Guizhou Medical University, Guizhou, China."}], "LastName": "Zhang", "ForeName": "Huifang", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guizhou, China."}, {"Identifier": [], "Affiliation": "International Scientific and Technological Cooperation Base of Pathogenesis and Drug Research on Common Major Diseases, Guizhou Medical University, Guizhou, China."}], "LastName": "Zhou", "ForeName": "Xingcheng", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guizhou, China."}, {"Identifier": [], "Affiliation": "International Scientific and Technological Cooperation Base of Pathogenesis and Drug Research on Common Major Diseases, Guizhou Medical University, Guizhou, China."}], "LastName": "Wang", "ForeName": "Dan", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guizhou, China."}, {"Identifier": [], "Affiliation": "International Scientific and Technological Cooperation Base of Pathogenesis and Drug Research on Common Major Diseases, Guizhou Medical University, Guizhou, China."}], "LastName": "Chen", "ForeName": "Rongyu", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guizhou, China."}], "LastName": "Tan", "ForeName": "Wanlin", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guizhou, China."}, {"Identifier": [], "Affiliation": "International Scientific and Technological Cooperation Base of Pathogenesis and Drug Research on Common Major Diseases, Guizhou Medical University, Guizhou, China."}], "LastName": "Liang", "ForeName": "Luqun", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guizhou, China."}, {"Identifier": [], "Affiliation": "International Scientific and Technological Cooperation Base of Pathogenesis and Drug Research on Common Major Diseases, Guizhou Medical University, Guizhou, China."}], "LastName": "Shi", "ForeName": "Mingjun", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guizhou, China."}, {"Identifier": [], "Affiliation": "International Scientific and Technological Cooperation Base of Pathogenesis and Drug Research on Common Major Diseases, Guizhou Medical University, Guizhou, China."}], "LastName": "Zhang", "ForeName": "Fan", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guizhou, China."}, {"Identifier": [], "Affiliation": "International Scientific and Technological Cooperation Base of Pathogenesis and Drug Research on Common Major Diseases, Guizhou Medical University, Guizhou, China."}], "LastName": "Xiao", "ForeName": "Ying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guizhou, China."}, {"Identifier": [], "Affiliation": "International Scientific and Technological Cooperation Base of Pathogenesis and Drug Research on Common Major Diseases, Guizhou Medical University, Guizhou, China."}], "LastName": "Zhou", "ForeName": "Yuxia", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guizhou, China."}, {"Identifier": [], "Affiliation": "International Scientific and Technological Cooperation Base of Pathogenesis and Drug Research on Common Major Diseases, Guizhou Medical University, Guizhou, China."}], "LastName": "Wang", "ForeName": "Yuanyuan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guizhou, China."}, {"Identifier": [], "Affiliation": "International Scientific and Technological Cooperation Base of Pathogenesis and Drug Research on Common Major Diseases, Guizhou Medical University, Guizhou, China."}], "LastName": "Guo", "ForeName": "Bing", "Initials": "B"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Athyros V. G., Katsiki N., Karagiannis A., Mikhailidis D. P. (2015). Statins Can Improve Proteinuria and Glomerular Filtration Rate Loss in Chronic Kidney Disease Patients, Further Reducing Cardiovascular Risk. Fact or Fiction. Expert Opin. Pharmacother. 16 (10), 1449\u20131461. 10.1517/14656566.2015.1053464", "ArticleIdList": ["10.1517/14656566.2015.1053464", "26037614"]}, {"Citation": "Bhargava P., Schnellmann R. G. (2017). Mitochondrial Energetics in the Kidney. Nat. Rev. Nephrol. 13 (10), 629\u2013646. 10.1038/nrneph.2017.107", "ArticleIdList": ["10.1038/nrneph.2017.107", "PMC5965678", "28804120"]}, {"Citation": "Cacicedo J. M., Benjachareowong S., Chou E., Ruderman N. B., Ido Y. (2005). Palmitate-induced Apoptosis in Cultured Bovine Retinal Pericytes: Roles of NAD(P)H Oxidase, Oxidant Stress, and Ceramide. Diabetes 54, 1838\u20131845. 10.2337/diabetes.54.6.1838", "ArticleIdList": ["10.2337/diabetes.54.6.1838", "15919807"]}, {"Citation": "Chen H., Chan D. C. (2004). Mitochondrial Dynamics in Mammals. Curr. Top. Dev. Biol. 59, 119\u2013144. 10.1016/S0070-2153(04)59005-1", "ArticleIdList": ["10.1016/S0070-2153(04)59005-1", "14975249"]}, {"Citation": "Chen H., Chomyn A., Chan D. C. (2005). Disruption of Fusion Results in Mitochondrial Heterogeneity and Dysfunction. J. Biol. Chem. 280 (28), 28026185\u201328026192. 10.1074/jbc.M503062200", "ArticleIdList": ["10.1074/jbc.M503062200", "15899901"]}, {"Citation": "Chung K. W., Lee E. K., Lee M. K., Oh G. T., Yu B. P., Chung H. Y. (2018). Impairment of PPAR\u03b1 and the Fatty Acid Oxidation Pathway Aggravates Renal Fibrosis during Aging. J. Am. Soc. Nephrol. 29 (4), 1223\u20131237. 10.1681/ASN.2017070802", "ArticleIdList": ["10.1681/ASN.2017070802", "PMC5875952", "29440279"]}, {"Citation": "Chuppa S., Liang M., Liu P., Liu Y., Casati M. C., Cowley A. W., et al. (2018). MicroRNA-21 Regulates Peroxisome Proliferator-Activated Receptor Alpha, a Molecular Mechanism of Cardiac Pathology in Cardiorenal Syndrome Type 4. Kidney Int. 93 (2), 375\u2013389. 10.1016/j.kint.2017.05.014", "ArticleIdList": ["10.1016/j.kint.2017.05.014", "PMC5787401", "28760335"]}, {"Citation": "Coughlan M. T., Sharma K. (2016). Challenging the Dogma of Mitochondrial Reactive Oxygen Species Overproduction in Diabetic Kidney Disease. Kidney Int. 90 (2), 272\u2013279. 10.1016/j.kint.2016.02.043", "ArticleIdList": ["10.1016/j.kint.2016.02.043", "27217197"]}, {"Citation": "Detmer S. A., Chan D. C. (2007). Functions and Dysfunctions of Mitochondrial Dynamics. Nat. Rev. Mol. Cel Biol. 8 (11), 870\u2013879. 10.1038/nrm2275", "ArticleIdList": ["10.1038/nrm2275", "17928812"]}, {"Citation": "Ducasa G. M., Mitrofanova A., Fornoni A. (2019). Crosstalk between Lipids and Mitochondria in Diabetic Kidney Disease. Curr. Diab. Rep. 2119 (12), 144. 10.1007/s11892-019-1263-x", "ArticleIdList": ["10.1007/s11892-019-1263-x", "31754839"]}, {"Citation": "Filipowicz W., Bhattacharyya S. N., Sonenberg N. (2008). Mechanisms of post-transcriptional Regulation by microRNAs: Are the Answers in Sight. Nat. Rev. Genet. 9 (2), 102\u2013114. 10.1038/nrg2290", "ArticleIdList": ["10.1038/nrg2290", "18197166"]}, {"Citation": "Galvan D. L., Green N. H., Danesh F. R. (2017). The Hallmarks of Mitochondrial Dysfunction in Chronic Kidney Disease. Kidney Int. 92 (5), 1051\u20131057. 10.1016/j.kint.2017.05.034", "ArticleIdList": ["10.1016/j.kint.2017.05.034", "PMC5667560", "28893420"]}, {"Citation": "Gerber P. A., Rutter G. A. (2017). The Role of Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in Diabetes Mellitus. Antioxid. Redox Signal. 126 (10), 501\u2013518. 10.1089/ars.2016.6755", "ArticleIdList": ["10.1089/ars.2016.6755", "PMC5372767", "27225690"]}, {"Citation": "Grabacka M., Pierzchalska M., Reiss K. (2013). Peroxisome Proliferator Activated Receptor \u03b1 Ligands as Anticancer Drugs Targeting Mitochondrial Metabolism. Curr. Pharm. Biotechnol. 14 (3), 342\u2013356. 10.2174/1389201011314030009", "ArticleIdList": ["10.2174/1389201011314030009", "PMC3631438", "21133850"]}, {"Citation": "Herman-Edelstein M., Scherzer P., Tobar A., Levi M., Gafter U. (2014). Altered Renal Lipid Metabolism and Renal Lipid Accumulation in Human Diabetic Nephropathy. J. Lipid Res. 55 (3), 561\u2013572. 10.1194/jlr.P040501", "ArticleIdList": ["10.1194/jlr.P040501", "PMC3934740", "24371263"]}, {"Citation": "Jao T. M., Nangaku M., Wu C. H., Sugahara M., Saito H., Maekawa H., et al. (2019). ATF6\u03b1 Downregulation of PPAR\u03b1 Promotes Lipotoxicity-Induced Tubulointerstitial Fibrosis. Kidney Int. 95 (3), 577\u2013589. 10.1016/j.kint.2018.09.023", "ArticleIdList": ["10.1016/j.kint.2018.09.023", "30639234"]}, {"Citation": "Jheng H. F., Tsai P. J., Guo S. M., Kuo L. H., Chang C. S., Su I. J., et al. (2012). Mitochondrial Fission Contributes to Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle. Mol. Cel Biol. 32 (2), 309\u2013319. 10.1128/MCB.05603-11", "ArticleIdList": ["10.1128/MCB.05603-11", "PMC3255771", "22083962"]}, {"Citation": "Jia Z., An L., Lu Y., Xu C., Wang S., Wang J., et al. (2019). Oxidized Low Density Lipoprotein-Induced Atherogenic Response of Human Umbilical Vascular Endothelial Cells (HUVECs) Was Protected by Atorvastatin by Regulating miR-26a-5p/Phosphatase and Tensin Homolog (PTEN). Med. Sci. Monit. 25 (25), 9836\u20139843. 10.12659/MSM.918405", "ArticleIdList": ["10.12659/MSM.918405", "PMC6938650", "31865360"]}, {"Citation": "Kang H. M., Ahn S. H., Choi P., Ko Y. A., Han S. H., Chinga F., et al. (2015). Defective Fatty Acid Oxidation in Renal Tubular Epithelial Cells Has a Key Role in Kidney Fibrosis Development. Nat. Med. 21 (1), 37\u201346. 10.1038/nm.3762", "ArticleIdList": ["10.1038/nm.3762", "PMC4444078", "25419705"]}, {"Citation": "Kim T. S., Jin Y. B., Kim Y. S., Kim S., Kim J. K., Lee H. M., et al. (2019). SIRT3 Promotes Antimycobacterial Defenses by Coordinating Mitochondrial and Autophagic Functions. Autophagy 15 (8), 1356\u20131375. 10.1080/15548627.2019.1582743", "ArticleIdList": ["10.1080/15548627.2019.1582743", "PMC6628940", "30774023"]}, {"Citation": "Kogawa A. C., Pires A. E. D. T., Salgado H. R. N. (2019). Atorvastatin: A Review of Analytical Methods for Pharmaceutical Quality Control and Monitoring. J. AOAC Int. 102 (3), 801\u2013809. 10.5740/jaoacint.18-0200", "ArticleIdList": ["10.5740/jaoacint.18-0200", "30563586"]}, {"Citation": "Liao D., Liu Y. Q., Xiong L. Y., Zhang L. (2016). Renoprotective Effect of Atorvastatin on STZ-Diabetic Rats through Inhibiting Inflammatory Factors Expression in Diabetic Rat. Eur. Rev. Med. Pharmacol. Sci. 20 (9), 1888\u20131893.", "ArticleIdList": ["27212184"]}, {"Citation": "Liu L., Wang Y., Yan R., Liang L., Zhou X., Liu H., et al. (2019). BMP-7 Inhibits Renal Fibrosis in Diabetic Nephropathy via miR-21 Downregulation. Life Sci. 238, 116957. 10.1016/j.lfs.2019.116957", "ArticleIdList": ["10.1016/j.lfs.2019.116957", "31655195"]}, {"Citation": "McKeage K., Keating G. M. (2011). Fenofibrate: a Review of its Use in Dyslipidaemia. Drugs 71 (14), 1917\u20131946. 10.2165/11208090-000000000-00000", "ArticleIdList": ["10.2165/11208090-000000000-00000", "21942979"]}, {"Citation": "Nozari E., Moradi A., Samadi M. (2020). Effect of Atorvastatin, Curcumin, and Quercetin on miR-21 and miR-122 and Their Correlation with TGF\u03b21 Expression in Experimental Liver Fibrosis. Life Sci. 259, 259118293. 10.1016/j.lfs.2020.118293", "ArticleIdList": ["10.1016/j.lfs.2020.118293", "32822714"]}, {"Citation": "Pose E., Trebicka J., Mookerjee R. P., Angeli P., Gin\u00e8s P. (2019). Statins: Old Drugs as New Therapy for Liver Diseases. J. Hepatol. 70 (1), 194\u2013202. 10.1016/j.jhep.2018.07.019", "ArticleIdList": ["10.1016/j.jhep.2018.07.019", "30075229"]}, {"Citation": "Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N., et al. (2019). Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Res. Clin. Pract. 157, 107843. 10.1016/j.diabres.2019.107843", "ArticleIdList": ["10.1016/j.diabres.2019.107843", "31518657"]}, {"Citation": "Simon N., Hertig A. (2015). Alteration of Fatty Acid Oxidation in Tubular Epithelial Cells: From Acute Kidney Injury to Renal Fibrogenesis. Front. Med. (Lausanne) 2 (2), 52. 10.3389/fmed.2015.00052", "ArticleIdList": ["10.3389/fmed.2015.00052", "PMC4525064", "26301223"]}, {"Citation": "Staiger K., Staiger H., Weigert C., Haas C., H\u00e4ring H. U., Kellerer M. (2006). Saturated, but Not Unsaturated, Fatty Acids Induce Apoptosis of Human Coronary Artery Endothelial Cells via Nuclear Factor-kappaB Activation. Diabetes 55, 3121\u20133126. 10.2337/db06-0188", "ArticleIdList": ["10.2337/db06-0188", "17065351"]}, {"Citation": "Su B., Han H., Ji C., Hu W., Yao J., Yang J., et al. (2020). MiR-21 Promotes Calcium Oxalate-Induced Renal Tubular Cell Injury by Targeting PPARA. Am. J. Physiol. Ren. Physiol. 319 (2), F202\u2013F214. 10.1152/ajprenal.00132.2020", "ArticleIdList": ["10.1152/ajprenal.00132.2020", "32628541"]}, {"Citation": "Verg\u00e8s B. (2020). Dyslipidemia in Type 1 Diabetes: AMaskedDanger. Trends Endocrinol. Metab. 31 (6), 422\u2013434. 10.1016/j.tem.2020.01.015", "ArticleIdList": ["10.1016/j.tem.2020.01.015", "32217073"]}, {"Citation": "Wang Y. X. (2010). PPARs: Diverse Regulators in Energy Metabolism and Metabolic Diseases. Cell Res. 20, 124\u2013137. 10.1038/cr.2010.13", "ArticleIdList": ["10.1038/cr.2010.13", "PMC4084607", "20101262"]}, {"Citation": "Xu Y., Wu Y. (2020). Atorvastatin Associated with Gamma Glutamyl Transpeptidase Elevation in a Hyperlipidemia Patient: A Case Report and Literature Review. Medicine (Baltimore) 99 (40), e22572. 10.1097/MD.0000000000022572", "ArticleIdList": ["10.1097/MD.0000000000022572", "PMC7535555", "33019469"]}, {"Citation": "Xu J., Xiao G., Trujillo C., Chang V., Blanco L., Joseph S. B., et al. (2002). Peroxisome Proliferator-Activated Receptor Alpha (PPARalpha) Influences Substrate Utilization for Hepatic Glucose Production. J. Biol. Chem. 277, 50237\u201350244. 10.1074/jbc.M201208200", "ArticleIdList": ["10.1074/jbc.M201208200", "12176975"]}, {"Citation": "Yu T., Robotham J. L., Yoon Y. (2006). Increased Production of Reactive Oxygen Species in Hyperglycemic Conditions Requires Dynamic Change of Mitochondrial Morphology. Proc. Natl. Acad. Sci. U S A. 21103 (8), 2653\u20132658. 10.1073/pnas.0511154103", "ArticleIdList": ["10.1073/pnas.0511154103", "PMC1413838", "16477035"]}, {"Citation": "Zhou J., Wang K. C., Wu W., Subramaniam S., Shyy J. Y., Chiu J. J., et al. (2011). MicroRNA-21 Targets Peroxisome Proliferators-Activated Receptor-Alpha in an Autoregulatory Loop to Modulate Flow-Induced Endothelial Inflammation. Proc. Natl. Acad. Sci. U S A. 108 (25), 10355\u201310360. 10.1073/pnas.1107052108", "ArticleIdList": ["10.1073/pnas.1107052108", "PMC3121870", "21636785"]}, {"Citation": "Zolezzi J. M., Silva-Alvarez C., Ordenes D., Godoy J. A., Carvajal F. J., Santos M. J., et al. (2013). Peroxisome Proliferator-Activated Receptor (PPAR) \u03b3 and PPAR\u03b1 Agonists Modulate Mitochondrial Fusion-Fission Dynamics: Relevance to Reactive Oxygen Species (ROS)-related Neurodegenerative Disorders. PLoS One 138 (5), e64019. 10.1371/journal.pone.0064019", "ArticleIdList": ["10.1371/journal.pone.0064019", "PMC3652852", "23675519"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "22"}, {"Year": "2022", "Month": "1", "Day": "5"}, {"Year": "2022", "Month": "2", "Day": "28", "Hour": "5", "Minute": "33"}, {"Year": "2022", "Month": "3", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "1", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "2", "Day": "11"}], "PublicationStatus": "epublish", "ArticleIdList": ["35222033", "PMC8874267", "10.3389/fphar.2022.819787", "819787"]}}], "PubmedBookArticle": []}